Skip to content
CityAM
Main navigation
  • News
    • News
      • Latest Business News
      • Economics
      • Politics
      • Tech
      • Banking
      • FTSE 100 Live
      • Retail
      • Insurance
      • Legal
      • Property
      • Transport
      • Markets
    • From our partners
      • AON
      • Bayes Business School
      • Canada BIDs
      • Central London Alliance CIC
      • Destination City
      • Halkin
      • Olympia
      • Inside Saudi
      • Tottenham Hotspur Stadium
      • Santander X
      • YEAR SIX Dividend
    • Featured

      Strait of Hormuz closed over ceasefire violations, says Iran

      Aerial view of ships navigating the strategic Strait of Hormuz, highlighting its importance to global maritime trade routes

      Submit a story

      Tell us your story.

      Submit
  • Opinion
  • Sport
    • Latest Sports News
      • Sport
      • Sport Business
    • From our partners
      • The Morning Briefing: SBS x CityAM
      • Aramco Team Series
      • LIV Golf
    • Featured

      Platitudes in women’s sport are empty, patronising and offensive

      Business professionals in a conference room discussing strategy with a presentation screen displaying key market trends.

      Submit a story

      Tell us your story.

      Submit
  • Life&Style
    • Life&Style
      • Life&Style
      • Toast the City Awards
      • The Magazine
      • Travel
      • Culture
      • Motoring
      • Wellness
      • The RED BULLETiN
      • Do it with Shared Ownership
      • Media Speak Hub
    • Featured

      Fogo de Chao nominated for Best Casual Dining Toast award

      Fogo de Chão restaurant exterior with vibrant signage and bustling entrance at popular city location

      Submit a story

      Tell us your story.

      Submit
  • Investec
  • Events
  • Latest Paper
Tuesday 16 March 2021 1:52 pm  |  Updated:  Wednesday 17 March 2021 9:48 am

EU medicines regulator: ‘No indication’ Astrazeneca vaccine causes blood clots

By: Poppy Wood

Add as a preferred source on Google

The EU’s medicines regulator has insisted there is “no indication” that Astrazeneca’s Covid vaccine causes blood clots among patients, after a swathe of European countries suspended the jab over safety concerns.

Emer Cooke, executive director of the European Medicines Agency (EMA), said the agency remains “firmly convinced” that the benefits of the Astrazeneca vaccine outweigh the risk of side-effects. 

Cooke added there were no signs to suggest that the estimated 17m Astrazeneneca vaccinations delivered across Europe have caused reported cases of blood clots.

“We know that many thousands of people develop thousands of clots annually for many different reasons”, she said, adding that the number of thromboembolic was the normal level among the general European population. 

News of the EMA’s continuing support appeared to calm investor nerves, with Astrazeneca shares up 3.2 per cent to 7,199.2p at market close.

It comes as Sweden this morning joined a list of 15 countries across Europe that have temporarily banned the jab following reports of blood clot-related deaths.

No such cases have been reported in Sweden but neighbouring Norway and Denmark have each reported one death.

France, Italy and Germany yesterday announced a temporary suspension of the jab while the EMA investigation is underway.

Read more

AAHI’s SLA-SE Adjuvant Technology Powers Lilly’s Acquisition of Curevo’s Next-Generation Shingles Vaccine

The EMA said on Friday there was no evidence of a link between the events and the jabs, stressing that “the vaccine’s benefits currently still outweigh the risks”. It urged countries to continue with their vaccination campaigns.

It will meet today to discuss the continued use of the jab across Europe, with a decision set to be announced on Thursday.

The World Health Organisation (WHO) has urged countries to continue using the vaccine as investigations into the reports continue.

UK leaders and medical professionals have united to insist on the jab’s safety, as Britain continues to prioritise the vaccine in its rapid immunisation programme.

The Prime Minister reiterated his support for the Astrazeneca vaccine on a visit to Coventry yesterday, insisting he was “very confident” it was safe and effective.

Dominic Raab, the UK’s foreign secretary, said it was “crystal clear” that the vaccine was safe and effective, pointing to support from regulators in Britain and the EU.

He told BBC Breakfast this morning: “There is no extra risk on the evidence that we’ve seen, which is why they have authorised the vaccine and haven’t taken any further action.

“We respect the process and procedures that some other countries may need to go through but the vaccine is safe and people should certainly continue to take it and to protect themselves and their friends and family.”

Read more

AviadoBio Presents Positive Preclinical Data for AVB-406 Program in Alzheimer’s Disease and Other Tauopathies at ASGCT 2026

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business
  • Politics

Related Topics

  • AstraZeneca
  • Coronavirus
  • Re-lockdown
  • Vaccine

Trending Articles

  • As it happened: Stocks sink after Fed and Bank of England opt for hawkish hold; Oil price tumbles

  • FTSE 100 Live: Pound dips and stocks slip as Andy Burnham victory triggers political uncertainty

  • City investors raise alarm on Burnham’s Chancellor pick

  • Inheritance tax enquiries surge to six-year high after HMRC clampdown

  • More Big Four blues as Deloitte plans to slash UK audit roles

More from CityAM

  • AAHI’s SLA-SE Adjuvant Technology Powers Lilly’s Acquisition of Curevo’s Next-Generation Shingles Vaccine

    Business Wire
  • AviadoBio Presents Positive Preclinical Data for AVB-406 Program in Alzheimer’s Disease and Other Tauopathies at ASGCT 2026

    Business Wire
  • Real Chemistry Appoints Healthcare Industry Leaders Frank Clyburn and Chris Fikry to Board of Directors

    Business Wire
  • Silence Therapeutics Highlights Follow-Up Data at EHA 2026 Demonstrating Durable Efficacy and Potential Best-in-Class Profile for Divesiran in Polycythemia Vera

    Business Wire
  • Realignment with the EU is a £15bn betrayal

    Opinion
    UK-EU border alignment discussion, highlighting £15bn GDP impact and trade concerns, with a focus on economic implications
  • ‘Languishing share price’: CVS under pressure to turn around performance from activist investor

    Business
    Veterinarian examining a cat in a clinic setting, highlighting professional care and attention in a pet health environment
  • Alkermes Announces Orphan Drug Designations for Alixorexton in the U.S. and Europe

    Business Wire
  • Silence Therapeutics to Participate in Jefferies Global Healthcare Conference

    Business Wire

CityAM Canada — business, markets and opinion for Canadian readers.

Sections

  • Business
  • Markets
  • Tech
  • AI
  • Economics
  • Opinion
  • Cities

Company

  • About
  • Contact

Legal

  • Terms of Use
  • Privacy Policy
  • Cookie Policy
© 2026 CityAM Canada. All rights reserved.
Terms · Privacy · Cookies